Sema Göğüş
Sema Göğüş has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Fehime Benli Aksungar
Biochemistry and Molecular Biology Department, Graduate School of Health Sciences, Acıbadem Mehmet AliAydınlar University, 34752 Istanbul, Turkey
1 shared publication - Ihsan Yozgat
Department of Medical Biotechnology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey
1 shared publication - Meltem Kilercik
Department of Biochemistry, Acibadem University, Istanbul, Turkiye
1 shared publication - Muhittin Abdulkadir Serdar
Department of Medical Biochemistry, School of Medicine, Acıbadem University, Ankara, Turkey
1 shared publication - Murat Yayla
From the Departments of Obstetrics & Gynecology
1 shared publication - Mustafa Serteser
Acıbadem University, Turkey (Türkiye)
1 shared publication
Latest Publications
- Open Access
- 12 July 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (6) , 704-709
What are the predominant parameters for Down syndrome risk estimation in first-trimester screening: a data mining study
Objectives: This study aimed to evaluate the effect size of each parameter used in the first trimester Down syndrome (DS) risk analyses by using multiple regression analysis techniques. Methods: This data mining study included data of 44,260 pregnant women screened at the Acibadem Labmed laboratories from 2010 to 2019. In this study, risk was calculated using the PRISCA software on the basis of nuchal translucency (NT), crown-rump length measurement, in vitro fertilization application, diabetes mellitus, Down syndrome story, smoking, maternal age, and the level of maternal serum biochemistry markers including pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (hCGβ). Results: Forty-four thousand two hundred sixty risk analysis patients result data were re-investigate, and 851 (1.93%) risk analysis results were found as positive. PAPP-A 747 (CI%, 476–1,170) times, NT value 512 (CI%, 343–764) times, DS story 21 times (CI%, 6.7–63.2) and hCGβ value 7.01 (CI%, 6.31–7.79) times affect the combined first-trimester risk analysis results. Conclusions: We have suggested that those accurate PAPP-A levels and NT levels evaluation are the most critical point of combined risk analysis and that the risk of free hCGβ levels after PAPP-A is essential as a biochemical test.
- 12 July 2022
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 47 (6) , 704-709
Open AccessWhat are the predominant parameters for Down syndrome risk estimation in first-trimester screening: a data mining study
Objectives: This study aimed to evaluate the effect size of each parameter used in the first trimester Down syndrome (DS) risk analyses by using multiple regression analysis techniques. Methods: This data mining study included data of 44,260 pregnant women screened at the Acibadem Labmed laboratories from 2010 to 2019. In this study, risk was calculated using the PRISCA software on the basis of nuchal translucency (NT), crown-rump length measurement, in vitro fertilization application, diabetes mellitus, Down syndrome story, smoking, maternal age, and the level of maternal serum biochemistry markers including pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (hCGβ). Results: Forty-four thousand two hundred sixty risk analysis patients result data were re-investigate, and 851 (1.93%) risk analysis results were found as positive. PAPP-A 747 (CI%, 476–1,170) times, NT value 512 (CI%, 343–764) times, DS story 21 times (CI%, 6.7–63.2) and hCGβ value 7.01 (CI%, 6.31–7.79) times affect the combined first-trimester risk analysis results. Conclusions: We have suggested that those accurate PAPP-A levels and NT levels evaluation are the most critical point of combined risk analysis and that the risk of free hCGβ levels after PAPP-A is essential as a biochemical test.